The Mexico hemostats market was valued at USD 160.27 Million in 2024 driven by the rapid technological advancements, with innovations in hemostatic agents such as fibrin sealants and advanced topical hemostats across the region. It is expected to grow at a CAGR of 5.50% during the forecast period of 2025-2034 and attain a market value of USD 273.76 Million by 2034.
The market is growing steadily, shaped by advances in surgical technology and the country’s shifting health profile. Hospitals are adopting newer hemostatic products, particularly fibrin sealants and advanced topical agents, which offer faster application and better outcomes in complex surgeries. This shift is driven by both public and private healthcare providers looking to improve surgical efficiency and patient recovery. Chronic diseases are a major factor. Cardiovascular disease, diabetes, and obesity are all on the rise in Mexico, contributing to a higher volume of surgical interventions, from bypass surgeries and angioplasties to amputations and wound care. These procedures often involve significant blood loss, making effective hemostasis critical.
Other key players in the market include Becton, Dickinson and Company (BD), Medtronic plc, and Stryker Corporation, among others.
This product will be delivered within 3-5 business days.
The market is growing steadily, shaped by advances in surgical technology and the country’s shifting health profile. Hospitals are adopting newer hemostatic products, particularly fibrin sealants and advanced topical agents, which offer faster application and better outcomes in complex surgeries. This shift is driven by both public and private healthcare providers looking to improve surgical efficiency and patient recovery. Chronic diseases are a major factor. Cardiovascular disease, diabetes, and obesity are all on the rise in Mexico, contributing to a higher volume of surgical interventions, from bypass surgeries and angioplasties to amputations and wound care. These procedures often involve significant blood loss, making effective hemostasis critical.
Mexico Hemostats Market Overview
Hemostats are widely used in Mexico to control bleeding during surgeries, trauma cases, and wound management, ensuring patient safety and reducing complications. They are essential in procedures like orthopedic, gynecological, cardiovascular, and general surgeries, especially given Mexico’s rising rates of chronic diseases, cesarean deliveries, and trauma incidents, which drive the need for effective hemostatic solutions in hospitals and surgical centers. The Mexico hemostats market is expected to grow at a CAGR of 5.50% during the forecast period of 2025-2034.Mexico Hemostats Market Growth Drivers
Adoption of Innovative Hemostats to Boost Market Value
Rising gastrointestinal disorder prevalence and increasing demand for minimally invasive procedures are key drivers for the market. For instance, in February 2021, EndoClot Plus, Inc. announced FDA approval for its EndoClot® Polysaccharide Hemostatic System (PHS), a starch-based powder that quickly forms a gelled matrix to control GI bleeding via endoscopy. As this product gains global adoption, including in emerging markets like Mexico, it is likely to bolster advanced hemostatic solution adoption, driving significant market growth in the forecast period.Mexico Hemostats Market Trends
The market is expanding due to rising cancer cases and increasing trauma-related surgical needs.Rising Cancer Burden Fueling Mexico Hemostats Market Growth
In 2022, Mexico recorded over 207,000 new cancer cases and nearly 96,210 deaths, highlighting the country’s growing oncology burden. With prevalent cases exceeding 577,000, surgical intervention remains critical, especially for prostate and breast cancer. This rising demand for surgeries directly fuels the need for effective intraoperative bleeding control, thereby driving the adoption of hemostats in Mexico’s healthcare landscape and contributing significantly to market growth during the forecast period.Increased Spinal Trauma Cases Bolstering Mexico Hemostats Market Demand
A 2022 study conducted at a Level III trauma center in Mexico reported 55 cases of spinal gunshot injuries over a two-year period (2018-2020), with a mortality rate of 5.45%. These findings underscore the significant burden of spinal injuries in Mexico, highlighting the need for effective hemostatic agents to manage bleeding and improve patient outcomes. The increasing incidence of trauma cases is expected to drive the demand for advanced hemostatic solutions, contributing to the growth of the hemostats market in Mexico during the forecast period.Mexico Hemostats Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Thrombin Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based
- Collagen Based
- Others
Market Breakup by Formulation
- Matrix and Gel Hemostats
- Sponge Hemostats
- Powder Hemostats
- Sheet and Pad
- Others
Market Breakup by Application
- Cardiovascular and Cardiothoracic
- Gynecological
- Urology
- Orthopedic Surgery
- General Surgery
- Plastic Surgery
- Ear, Nose and Throat (ENT), Head and Neck Surgery
- Others
Market Breakup by Indication
- Closure
- Surgery
Market Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Casualty Care Centers
- Others
Mexico Hemostats Market Share
Matrix and Gel Based Hemostats to Lead the Market Share by Formulation
Matrix and gel hemostats are likely to hold the largest share of the market. Their dominance is attributed to their superior efficacy in controlling bleeding during complex surgeries, versatility across various surgical specialties, and rapid adoption by surgeons seeking advanced solutions. As per the analysis by Expert Market Research, the global hemostats market size is expected to grow at a CAGR of 6.40% during the forecast period of 2025-2034. Additionally, matrix and gel formulations are preferred for their ease of use and ability to conform to irregular wound surfaces, supporting better surgical outcomes.Leading Players in the Mexico Hemostats Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:Johnson and Johnson Services Inc
Headquartered in New Brunswick, New Jersey, Johnson and Johnson Services Inc. was established in 1886. The company is a global healthcare leader, offering a diverse range of medical devices, pharmaceuticals, and consumer health products. In Mexico’s hemostats market, its Ethicon division delivers advanced hemostatic solutions like SURGICEL, widely used in surgeries for effective bleeding control.Baxter International
Baxter International, founded in 1931 and headquartered in Deerfield, Illinois, is a leading global MedTech company. In the Mexico hemostats market, Baxter provides a robust portfolio of hemostatic agents and sealants, including innovative products like Floseal and the recently launched Hemopatch Sealing Hemostat, which offers rapid, effective hemostasis for both open and minimally invasive surgeries.Pfizer Inc
Pfizer Inc., established in 1849 and based in New York City, is a renowned pharmaceutical and biotechnology company. In Mexico, Pfizer contributes to the hemostats market through its specialized biopharmaceuticals and partnerships, offering advanced solutions that support surgical teams in managing bleeding and improving patient outcomes during complex procedures.B. Braun SE
B. Braun SE, founded in 1839 and headquartered in Melsungen, Germany, is a global leader in healthcare products and services. In Mexico’s hemostats market, B. Braun offers a comprehensive range of surgical hemostatic agents and wound care solutions, supporting hospitals and surgical centers with reliable, innovative products for effective intraoperative bleeding management.Other key players in the market include Becton, Dickinson and Company (BD), Medtronic plc, and Stryker Corporation, among others.
Key Questions Answered in the Mexico Hemostats Market
- What was the Mexico hemostats market value in 2024?
- What is the Mexico hemostats market forecast outlook for 2025-2034?
- What are the major factors aiding the Mexico hemostats market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Mexico hemostats market trends?
- Which type will lead the market segment?
- Which formulation will lead the market segment?
- Which application will lead the market segment?
- Which indication will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the Mexico hemostats market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Hemostats Market Overview
4 Mexico Hemostats Market Landscape*
5 Mexico Hemostats Market Dynamics
6 Mexico Hemostats Market Segmentation (218-2034)
8 Patent Analysis
9 Funding and Investment Analysis
10 Strategic Initiatives
11 Supplier Landscape
12 Mexico Hemostats Market - Distribution Model (Additional Insight)
Companies Mentioned
- Johnson and Johnson Services Inc.
- Baxter International
- Pfizer Inc.
- B. Braun SE
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | June 2025 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 160.27 Million |
| Forecasted Market Value ( USD | $ 273.76 Million |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Mexico |
| No. of Companies Mentioned | 4 |
